![](/img/cover-not-exists.png)
T-Cell Depleted Allogeneic HSCT for Patients with Relapsed, High-Risk Multiple Myeloma Permits Long-Lasting Remissions in the Absence of Graft-Versus-Host Disease and Provides a Platform for Adoptive Immunotherapeutic Approaches
Koehne, Guenther, Devlin, Sean, Landau, Heather, Hassoun, Hani, Lesokhin, Alexander M., Lendvai, Nikoletta, Chung, David J., Bravo, Christina, Giralt, Sergio A.Volume:
20
Language:
english
Journal:
Biology of Blood and Marrow Transplantation
DOI:
10.1016/j.bbmt.2013.12.028
Date:
February, 2014
File:
PDF, 54 KB
english, 2014